|
|
Post by me on Jan 5, 2016 17:28:11 GMT -5
The CC did not address, either way, my question above. I need to know when DeSisto learned about the termination of the agreement. If he knew it was reasonably expected when he signed on, I'm still excited...if the termination caught him by surprise, then I have grave concerns and MNKD will soon have the dubious distinction of displacing JDSU as my all-time biggest loss. If he was caught completely by surprise, and elects to remain, he'll have to be one heckuva CEO to recover and get MNKD back on the rails. Now we'll see just what he's made of!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 5, 2016 17:33:11 GMT -5
The CC did not address, either way, my question above. I need to know when DeSisto learned about the termination of the agreement. If he knew it was reasonably expected when he signed on, I'm still excited...if the termination caught him by surprise, then I have grave concerns and MNKD will soon have the dubious distinction of displacing JDSU as my all-time biggest loss. If he was caught completely by surprise, and elects to remain, he'll have to be one heckuva CEO to recover and get MNKD back on the rails. Now we'll see just what he's made of! IMO he had to know. Everyone knew even retail thought it but we didnt want to believe it. The jabs Matt made about price and marketing strategy makes me think they knew this was coming and was probably an argument between MNKD and SNY. Matt sets up the JPM conference as a big stage for MNKD. |
|
|
|
Post by goyocafe on Jan 5, 2016 17:33:44 GMT -5
The CC did not address, either way, my question above. I need to know when DeSisto learned about the termination of the agreement. If he knew it was reasonably expected when he signed on, I'm still excited...if the termination caught him by surprise, then I have grave concerns and MNKD will soon have the dubious distinction of displacing JDSU as my all-time biggest loss. If he was caught completely by surprise, and elects to remain, he'll have to be one heckuva CEO to recover and get MNKD back on the rails. Now we'll see just what he's made of! My vote is he was made aware of the contentious situation with SNY and that there were serious issues with the arrangement, note Matt's reference to pricing and strategy. They didn't just realize this yesterday, so unless they withheld this from DeSisto, he knew/knows what he's getting himself in to. |
|
|
|
Post by peppy on Jan 5, 2016 17:37:27 GMT -5
I heard matt say Mannkind found out yesterday. I also heard Matt say they knew late summer there was a problem and started to look into...
I say bologna that Mannkind didn't know. I think Al Mann came back because he knew Sanofi was going to drop Afrezza and Desisto hired knowing what the job would be.
What I heard Matt say is; officially got word yesterday.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 5, 2016 17:41:25 GMT -5
I heard matt say Mannkind found out yesterday. I also heard Matt say they knew late summer there was a problem and started to look into...
I say bologna that Mannkind didn't know. I think Al Mann came back because he knew Sanofi was going to drop Afrezza and Desisto hired knowing what the job would be.
What I heard Matt say is; officially got word yesterday.
Exactly and lets make it look like the CEO was no prepared for this on the first day. Deflection? |
|
|
|
Post by bioexec25 on Jan 5, 2016 17:48:29 GMT -5
Interesting back and forth. Well if Mnkd did not know then they were pretty strategic in their planning with CEO, full stop.
If they did not have some warning then yes luckily they found a CEO with experience in "partner breakups" as DeSisto has this strength.
Come on folks. Retails last to know always and forever with this current government.
I'm waiting it out because at a minimum the assets and patents are worth triple this bullshit, strategic value notwithstanding.
|
|
|
|
Post by bthomas55ep on Jan 5, 2016 17:49:40 GMT -5
The CC did not address, either way, my question above. I need to know when DeSisto learned about the termination of the agreement. If he knew it was reasonably expected when he signed on, I'm still excited...if the termination caught him by surprise, then I have grave concerns and MNKD will soon have the dubious distinction of displacing JDSU as my all-time biggest loss. If he was caught completely by surprise, and elects to remain, he'll have to be one heckuva CEO to recover and get MNKD back on the rails. Now we'll see just what he's made of! My vote is he was made aware of the contentious situation with SNY and that there were serious issues with the arrangement, note Matt's reference to pricing and strategy. They didn't just realize this yesterday, so unless they withheld this from DeSisto, he knew/knows what he's getting himself in to. And perhaps he also knew of foreign interest like a Takeda that would have interest in buying the Afrezza franchise for say $1 Billion to take to Asia without a black box warning and inhaling medications or smoking is not an issue. Matt reiterates that TS is the future. My gut tells me the option to retain, market, and grow Afrezza as Mannkind is now gone. So get $2.50 a share for Afrezza, wipe out all your debts, put $750 Million in the bank, and sign a couple TS exploration partnerships - and bang - you have $6 bucks a share with the promise and hope of delivering a blockbuster. If the Asians have luck with Afrezza, they come back for another bigger bite for Pain and Duane's options go from $1.50. (unless they priced today) to $10 bucks in 5 years. There's a cool $80 Million Net. I think he's still in despite being absent at today's CC. Maybe on a flight to Tokyo? |
|
abwo
Newbie
Posts: 16 
|
Post by abwo on Jan 5, 2016 18:28:04 GMT -5
The CC did not address, either way, my question above. I need to know when DeSisto learned about the termination of the agreement. If he knew it was reasonably expected when he signed on, I'm still excited...if the termination caught him by surprise, then I have grave concerns and MNKD will soon have the dubious distinction of displacing JDSU as my all-time biggest loss. If he was caught completely by surprise, and elects to remain, he'll have to be one heckuva CEO to recover and get MNKD back on the rails. Now we'll see just what he's made of! I think exactly the same. The only thing that matters to me about the SNY termination is to make sure Duane took on the challenge knowing fully what was gonna happen. If he did, I believe the future holds some promise! It seems reasonable to believe that's true. - Fact : Monday was the FIRST day SNY could terminate the contract as per the details of the agreement. Do you really think people@SNY took such a decision over New Year's Eve? So...Rewinding the past months, everything seems pretty logical. It's been a few months that script numbers don't really rise anymore, or at least let's put it this way, don't seem to be the result of a sincere and big sales push forward by SNY. So a few months ago, less or maybe much more, SNY took the decision to stop. They HAD per contract to wait until yesterday for termination and to ensure a minimum sales & marketing effort. - Fact: they did wait until yesterday and did a minimum for sales & marketing to reduce their associated cost, as they knew they were gonna terminate the agreement anyway. - Fact: as Matt stated, MNKD has fought a lot of other battles and has prevailed. Remember all the CRLs? Remember how we all thought back then approval by FDA was the "saint graal"? It was probably only the first half of it, but it doesn't mean we won't get to the second half (sales)! And before I'm accused of pumping the stock what I'm saying is just that MNKD has demonstrated way more resources and perseverance that most companies. And they did get the FDA approval, which is huge when you think about it. - Fact: Afrezza is effective and has not yet shown any adverse effects, only huge benefits. THIS is the only thing that ever really worried me: the actual "real world" patient use of the drug. Will it be effective? Or would adverse effects that would never have been detected in the trials suddenly appear because of an uncontrolled population sample? I remember each and every real bad news (talk about CRLs...) which put us down even more than today (admittedly sp was starting higher, but finally it hurts less to loose 50% with a low cost base, than 80% with a high cost base  . So Hakan don't want to fight this new battle, or just was not the right person for this upcoming job. They hire a new CEO just in time: pretty big challenge indeed, but fact: MNKD still has two goldmines, with Afrezza and TS, as stated again by Matt today. I surprised myself to feel like each CRL nights today. Bitter for all the guys working hard at MNKD, but not at all shaken in my belief that MNKD will ultimately succeed. Call it sheer blindness, but SNY bailing us is nothing else than a CRL: a failure to achieve a goal: finding the best way to sell Afrezza to its full potential. We made it thru 2 CRLs with 0 revenue. We'll make it trough one wrong partner with some revenue associated for the first time at last As usual: never invest anything you can't afford to loose, and never trust anybody on a message board. That's why I never ever cared about the sp. We all have our own reasons to be invested in this stock, as long as you're good with them, then we should all be fine with today's events. So now I'll wait until the next public communication, presumably the JPM conference, to know wether Duane is stepping up and taking on the challenge or if not : what is the plan now. Will probably be very interesting! 8 years (and counting of an interesting journey for me so far, with big ups and downs, but never once did I feel bad about it. Keep it up! Good luck to all longs, Abwo |
|
|
|
Post by mnholdem on Jan 5, 2016 18:46:09 GMT -5
I mentioned this in another post, but I'll repeat it here. Go and read the PR announcing DeSisto's appointment. It was clearly stated that DeSisto would be working on improvement of Afrezza's commercialization. The fact that Sanofi was not mentioned indicates that Sanofi had already served notice of their intent to terminate. In my opinion, DeSisto knew Sanofi was terminating the agreement and then accepted the CEO job.
|
|
abwo
Newbie
Posts: 16
|
Post by abwo on Jan 5, 2016 18:57:54 GMT -5
I mentioned this in another post, but I'll repeat it here. Go and read the PR announcing DeSisto's appointment. It was clearly stated that DeSisto would be working on improvement of Afrezza's commercialization. The fact that Sanofi was not mentioned indicates that Sanofi had already served notice of their intent to terminate. In my opinion, DeSisto knew Sanofi was terminating the agreement and then accepted the CEO job. Fully agreed. Hence exciting - more than watching SNY from the sideline not be effective. My first personal hint was a chat with a guy from SNY a few months ago, outside the diabete division. I alluded to Afrezza and he was almost laughing like "yeah right, inhaled insulin!". Weird...when my company licenses a new product everybody is excited about it, not ironic. Anyway, time will tell! |
|
|
|
Post by obamayoumama on Jan 5, 2016 19:38:03 GMT -5
I mentioned this in another post, but I'll repeat it here. Go and read the PR announcing DeSisto's appointment. It was clearly stated that DeSisto would be working on improvement of Afrezza's commercialization. The fact that Sanofi was not mentioned indicates that Sanofi had already served notice of their intent to terminate. In my opinion, DeSisto knew Sanofi was terminating the agreement and then accepted the CEO job. Does anyone here think that MNKD was happy with SNY's job of marketing Afrezza? MNKD knew the divorce was coming. They fired Hakkan and hired DeSisto to handle the 2nd launch. It is actually better that SNY gave notice so that MNKD didn't have to prove that SNY was not doing their part of the agreement. MNKD is now free to market Afrezza, they have a clean slate to do what they want and price the product the way they want. No I don't believe they will sell it themselves, but bringing in a partner for a Country like Isreal is simple. They had put too much trust in SNY. Remember Hakkan had commented on a new API with Tech. before the end of the year. I think we will hear something shortly which should be the first of many. |
|
|
|
Post by factspls88 on Jan 5, 2016 20:07:32 GMT -5
I mentioned this in another post, but I'll repeat it here. Go and read the PR announcing DeSisto's appointment. It was clearly stated that DeSisto would be working on improvement of Afrezza's commercialization. The fact that Sanofi was not mentioned indicates that Sanofi had already served notice of their intent to terminate. In my opinion, DeSisto knew Sanofi was terminating the agreement and then accepted the CEO job. I agree with you 100%. That said, my take at the time of DeSisto's appointment was that MNKD was not happy with how Hakan was managing the relationship with Sanofi (i.e. unable to get the proper marketing support for Afrezza, either qualititatively or quantitatively) and that DeSisto was brought in to help right that situation. Given that the 35/65 split put all the power on Sanofi's side, I wasn't so sure that bringing in DeSisto was going to make a big difference. With today's action, bringing DeSisto in all makes sense. |
|
. So Hakan don't want to fight this new battle, or just was not the right person for this upcoming job. They hire a new CEO just in time: pretty big challenge indeed, but fact: MNKD still has two goldmines, with Afrezza and TS, as stated again by Matt today. 
